A pilot study investigating the efficacy of botanical anti-inflammatory agents in an OTC eczema therapy.

Zoe Diana Draelos
Zoe Diana Draelos
Wake Forest University School of Medicine
United States

J Cosmet Dermatol 2016 Jun 24;15(2):117-9. Epub 2015 Nov 24.

Dermatology Consulting Services, High Point, NC, USA.

Background: Eczema is a frequently encountered dermatologic condition characterized by inflammation resulting in erythema, scaling, induration, and lichenification.

Aims: The objective of this research was to examine the roll of botanical anti-inflammatories in alleviating the signs and symptoms of mild-to-moderate eczema.

Method: A total of 25 subjects 18+ years of age with mild-to-moderate eczema were asked to leave all oral medications and cleansers unchanged substituting the botanical study moisturizer for all topical treatment three times daily for 2 weeks. Investigator, subject, and noninvasive assessments were obtained at baseline and week 2.

Results: There was a highly statistically significant (P < 0.001) improvement in investigator-assessed irritation, erythema, desquamation, roughness, dryness, lichenification, itching, and overall skin appearance after 2 weeks of botanical anti-inflammatory moisturizer use. Overall, a 79% reduction in itching was noted. Skin hydration as measured by corneometry increased 44% increase (P < 0.001).

Conclusions: The study moisturizer containing the occlusive ingredients of dimethicone and shea butter oil; the humectant ingredients of glycerin, vitamin B, sodium PCA, and sodium hyaluronate; the barrier repair ingredients of ceramide 3, cholesterol, phytosphingosine, ceramide 6 II, and ceramide 1; and the botanical anti-inflammatories allantoin and bisabolol were helpful in reducing the signs and symptoms of mild-to-moderate eczema.

Download full-text PDF

http://dx.doi.org/10.1111/jocd.12199DOI Listing
June 2016
26 Reads

Publication Analysis

Top Keywords

symptoms mild-to-moderate
itching skin
botanical anti-inflammatory
signs symptoms
botanical anti-inflammatories
mild-to-moderate eczema
study moisturizer
oil humectant
treatment three
humectant ingredients
three times
daily weeks
shea butter
subject noninvasive
noninvasive assessments
investigator subject
weeks investigator
topical treatment
butter oil

Similar Publications

Assessing the Value of Botanical Anti-Inflammatory Agents in an OTC Acne Treatment Regimen.

J Drugs Dermatol 2015 Dec;14(12):1418-21

Background: Over-the-counter acne treatments have assumed more importance for the dermatologist as access and affordability of prescription acne medications has decreased.

Aim: This research evaluated the efficacy of a three step acne treatment regimen containing stabilized botanical anti-inflammatory ingredients as compared to a currently marketed acne regimen.

Method: 80 female/male subjects 12+ years with mild to moderate acne (at least 10 inflammatory and 10 non-inflammatory lesions) were enrolled for 12 weeks and randomized to use the study botanical anti-inflammatory acne regimen or the traditional benzoyl peroxide comparator. Read More

View Article
December 2015

Emollients and moisturisers for eczema.

Cochrane Database Syst Rev 2017 02 6;2:CD012119. Epub 2017 Feb 6.

Dutch Association for People with Atopic Dermatitis (VMCE: Vereniging voor Mensen met Constitutioneel Eczeem), PO Box 26, Nijkerk, Netherlands, NL-3860AA.

Background: Eczema is a chronic skin disease characterised by dry skin, intense itching, inflammatory skin lesions, and a considerable impact on quality of life. Moisturisation is an integral part of treatment, but it is unclear if moisturisers are effective.

Objectives: To assess the effects of moisturisers for eczema. Read More

View Article
February 2017

An over-the-counter moisturizer is as clinically effective as, and more cost-effective than, prescription barrier creams in the treatment of children with mild-to-moderate atopic dermatitis: a randomized, controlled trial.

J Drugs Dermatol 2011 May;10(5):531-7

Department of Dermatology,Wake Forest University School of Medicine,Winston-Salem, NC 27104, USA.

Background: Atopic dermatitis (AD) is a prevalent skin disorder with significant cost of treatment. Several prescription device moisturizers have been approved by the FDA to treat AD but are significantly more expensive than well-crafted over-the-counter (OTC) moisturizers. No studies have been performed to compare both the clinical efficacy and cost-efficacy of these prescription devices to OTC moisturizers. Read More

View Article
May 2011

Use of nonprescription topical steroids: patients' experiences.

Br J Dermatol 2005 Jun;152(6):1193-8

Department of Pharmacy & Pharmacology, University of Bath, Bath BA2 7AY, UK.

Background: Topical steroids became available, without prescription, in the U.K. in 1987, with hydrocortisone 1% cream first being licensed for irritant contact dermatitis and reactions to insect bites. Read More

View Article
June 2005